You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Phase II

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oropharyngeal Cancer, Squamous Cell Carcinoma of the Oropharynx Trial in Ann Arbor (procedure, combination product, other,

Recruiting
  • Oropharyngeal Cancer
  • Squamous Cell Carcinoma of the Oropharynx
  • Surgery
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
May 30, 2023

Breast Cancer, Brain Metastases, Radiotherapy Trial in Shanghai (Combination use of SRT with T-DXd)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Combination use of SRT with T-DXd
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 14, 2023

Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)

Not yet recruiting
  • Kaposi Sarcoma
  • +2 more
  • Pembrolizumab + Lenvatinib
  • (no location specified)
Apr 27, 2023

Foot Drop, Stroke, Hemiparesis Trial in Baltimore (Unpowered Physical Therapy Robot (Phase I/Phase II), PTR Physical Therapy

Recruiting
  • Foot Drop
  • +2 more
  • PTR Physical Therapy while wearing Robot group (Phase II)
  • +3 more
  • Baltimore, Maryland
    University of Maryland Rehabilitation & Orthopaedic Institute
Jan 24, 2023

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting
  • Gland
  • Salivary Gland Cancers
  • Sacituzumab Govitecan
  • Houston, Texas
    M D Anderson Cancer Center
May 22, 2023

Prostate Cancer Trial (ADT, Enzalutamide, Talazoparib)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
May 15, 2023

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Carcinomatosis
  • Houston, Texas
    M D Anderson Cancer Center
Aug 7, 2023

Colon Cancer Trial in Houston (Cemiplimab)

Not yet recruiting
  • Colon Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2023

Prostate Cancer Trial in Milan (68Ga-PSMA, 68Ga-RM2)

Completed
  • Prostate Cancer
  • Milan, Italy
    IRCCS Ospedale San Raffaele
Apr 5, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

Unresectable Lung Non-Small Cell Carcinoma Trial (serplulimab plus chemo as conversion treatment)

Not yet recruiting
  • Unresectable Lung Non-Small Cell Carcinoma
  • serplulimab plus chemotherapy as conversion treatment
  • (no location specified)
Apr 27, 2023

Wolfram Syndrome Trial (AMX0035)

Not yet recruiting
  • Wolfram Syndrome
  • (no location specified)
Dec 22, 2022

Distracted Driving Trial in Philadelphia (Intervention, Control)

Not yet recruiting
  • Distracted Driving
  • Intervention
  • Control
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Dec 6, 2022

Retinitis Pigmentosa Trial (1.5 x 10^6 UC-MSC + CM, 5 x 10^6 UC-MSC + CM)

Not yet recruiting
  • Retinitis Pigmentosa
  • 1.5 x 10^6 UC-MSC + CM
  • 5 x 10^6 UC-MSC + CM
  • (no location specified)
Jun 11, 2023

Infection of Upper Respiratory Tract Caused by 2019-nCoV Trial in Shanghai (SA55 Injection)

Recruiting
  • Infection of Upper Respiratory Tract Caused by 2019-nCoV
  • SA55 Injection
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 12, 2023

Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)

Not yet recruiting
  • Prostate Cancer
  • Phase I:[177Lu]Lu-XT033 Injection
  • Phase II:[177Lu]Lu-XT033 Injection
  • Beijing, Beijing, China
  • +1 more
Oct 7, 2023

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Obstructive Sleep Apnea Trial in Ann Arbor (Obstructive Sleep Apnea Screening Device)

Terminated
  • Obstructive Sleep Apnea
  • Obstructive Sleep Apnea Screening Device
  • Ann Arbor, Michigan
    University of Michigan
Jan 25, 2023

Chronic Low Back Pain Trial in Durham (Pregnenolone, DHEA, Placebo)

Not yet recruiting
  • Chronic Low Back Pain
  • Durham, North Carolina
    Durham VA Medical Center, Durham, NC
Jul 11, 2023

Breast Cancer Trial in Nanjing (Disitamb Vedotin ,pyrotinib)

Not yet recruiting
  • Breast Cancer
  • Disitamb Vedotin ,pyrotinib
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Aug 18, 2023

CCHF Trial (Favipiravir, Ribavirin)

Not yet recruiting
  • CCHF
  • (no location specified)
Jul 7, 2023

Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

Not yet recruiting
  • Metastatic Triple-Negative Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
Aug 31, 2023

Health Status, Anxiety, Depression, and 90-day Readmission Trial (Phase II comprehensive cardiac rehabilitation program)

Not yet recruiting
  • Health Status, Anxiety, Depression, and 90-day Readmission
  • Phase II comprehensive cardiac rehabilitation program
  • (no location specified)
Nov 3, 2023